Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-007032
Filing Date
2024-03-06
Accepted
2024-03-06 16:25:53
Documents
2
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 form4-03062024_090333.html 4  
1 form4-03062024_090333.xml 4 5751
2 ex24-03062024_090333.htm EX-24 7706
  Complete submission text file 0001415889-24-007032.txt   14881
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BLUEPRINTS MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
McCain Tracey L (Reporting) CIK: 0001683600 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 24726279